Striking Effect of Hydroxamic Acid Substitution on the Phosphodiesterase Type 4 (PDE4) and TNFα Inhibitory Activity of Two Series of Rolipram Analogues: Implications for a New Active Site Model of PDE4

This publication has 10 references indexed in Scilit:

• Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNFα generation from human monocytes by interacting with a ‘low‐affinity’ phosphodiesterase 4 conformer
  British Journal of Pharmacology, 1996
• Introduction of a conformational switching element on a pyrrolidine ring. Synthesis and evaluation of methyl (R*,R*)-(.+-.)-3-acetyl-4-[3- (cyclopentyloxy)-4-methoxyphenyl]-3- methyl-1-pyrrolidinecarboxylate, a potent and selective inhibitor of cAMP-specific phosphodiesterase.
  Journal of Medicinal Chemistry, 1995
• Review Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Inhibitors of TNFα synthesis
  Expert Opinion on Therapeutic Patents, 1995
• The effects of antiinflammatory and antiallergic drugs on cytokine release after stimulation of human whole blood by lipopolysaccharide and zymosan A
  Inflammation Research, 1995
• Zinc interactions and conserved motifs of the cGMP-binding cGMP-specific phosphodiesterase suggest that it is a zinc hydrolase.
  Journal of Biological Chemistry, 1994
• Phosphodiesterase inhibitors: new opportunities for the treatment of asthma.
  Thorax, 1991
• Selenosulfonation of conjugated enynes and the enyne equivalent 1,4-dichloro-2-butyne. Preparation of sulfonyl-substituted allenic alcohols and dienes using [2,3] sigmatropic rearrangements and organocuprate additions
  The Journal of Organic Chemistry, 1990
• Vertebrate collagenase inhibitor. I. Tripeptidyl hydroxamic acids.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1990
• N-Methylation of O-benzyl-.alpha.-N-(alkoxycarbonyl)-.alpha.-amino acid hydroxamate derivatives
  The Journal of Organic Chemistry, 1981
• Conversion of amides to thiol acids and isothiocyanates. Novel method for breaking of the amide bond
  Journal of the American Chemical Society, 1973